Anti-IL-6R antibody/CD47 fusion protein (Beijing Vdjbio)

抗IL-6R/CD47 融合蛋白（北京伟德杰生物）

Report date: 2025/06/04 15:13:24

Base Information

Drug NameAnti-IL-6R antibody/CD47 fusion protein (Beijing Vdjbio)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionAnti-Cluster of differentiation 47IL-6 receptor antagonists
TargetsCluster of differentiation 47IL-6 receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing Vdjbio Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Vdjbio Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A